SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2024-06-21 (enfarma.lat)
Synthon launches new alternatives for bioequivalent and biocomparable treatments for cancer in Mexico
Release. Synthon, a European pharmaceutical company focused on oncological and highly specialized bioequivalents and biocomparables, announced that it launched two new cancer therapies to the Mexican market.
Read more